KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Divestments (2017 - 2025)

Historic Divestments for Bausch Health Companies (BHC) over the last 9 years, with Q3 2025 value amounting to $7.0 million.

  • Bausch Health Companies' Divestments rose 4000.0% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $7.0 million for FY2024, which is 4000.0% up from last year.
  • Latest data reveals that Bausch Health Companies reported Divestments of $7.0 million as of Q3 2025, which was up 4000.0% from $5.0 million recorded in Q3 2024.
  • Bausch Health Companies' Divestments' 5-year high stood at $644.0 million during Q3 2021, with a 5-year trough of $1.0 million in Q2 2023.
  • For the 5-year period, Bausch Health Companies' Divestments averaged around $69.3 million, with its median value being $4.5 million (2021).
  • In the last 5 years, Bausch Health Companies' Divestments tumbled by 8095.24% in 2021 and then skyrocketed by 4000.0% in 2025.
  • Bausch Health Companies' Divestments (Quarter) stood at $644.0 million in 2021, then plummeted by 99.22% to $5.0 million in 2022, then decreased by 20.0% to $4.0 million in 2023, then rose by 25.0% to $5.0 million in 2024, then soared by 40.0% to $7.0 million in 2025.
  • Its Divestments stands at $7.0 million for Q3 2025, versus $5.0 million for Q3 2024 and $1.0 million for Q2 2024.